Hospitals Segment to be Largest Contributor to Ferritin Testing Market During 2020–2027
According to our latest study on “Ferritin Testing Market Forecast to 2027 – COVID-19 Impact and Analysis – by Indication and End User,” the market was valued at US$ 372.05 million in 2019 and is projected to reach US$ 556.19 million by 2027; it is expected to grow at a CAGR of 5.3% from 2020 to 2027. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
The increasing prevalence of anemia, aging population, and malnutrition is driving the demand for ferritin testing globally to measure the level of iron in blood. In Europe, economies are severely affected due to the increase in the number of COVID-19 cases. Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Lockdowns are being reintroduced across Europe, and healthcare institutions are focusing in the management of COVID-19 cases. The rising number of cases and imposed restrictions are expected to negatively impact the market growth.
Based on end user, the ferritin testing market is segmented into hospitals, diagnostic laboratories, and specialty clinics. The hospitals segment held the largest share of the market in 2019; whereas, the diagnostic laboratories segment is anticipated to register the highest CAGR during the forecast period. Increasing number of hospital admissions coupled with increasing prevalence of iron deficiency are projected to drive the growth of the hospital segment in the global ferritin testing market during the forecast period.
Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., bioMérieux SA, Doctorcall, Aviva Systems Biology Corporation, Biopanda Reagents Ltd, Monobind Inc., Orgentec Diagnostika, Thermo Fisher Scientific Inc, and Sekisui Diagnostic are among the leading companies operating in the global ferritin testing market.
The report segments global ferritin testing market as follows:
By Indication
- Anemia
- Hemochromatosis
- Pregnancy
- Lead Poisoning
By End User
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
By Geography
- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Contact UsContact Person: Sameer Joshi Phone: +1-646-491-9876
Email Id: sales@reportsweb.com
